(Q45111702)

English

Does administration of infliximab increase susceptibility to listeriosis?

scientific article published in March 2000

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10710107

retrieved

9 December 2017

title

Does administration of infliximab increase susceptibility to listeriosis? (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9 December 2017

0 references

Morelli J

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10710107

retrieved

9 December 2017

Wilson FA

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10710107

retrieved

9 December 2017

language of work or name

English

0 references

publication date

1 March 2000

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10710107

retrieved

9 December 2017

published in

The American Journal of Gastroenterology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10710107

retrieved

9 December 2017

volume

95

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10710107

retrieved

9 December 2017

issue

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10710107

retrieved

9 December 2017

page(s)

841-842

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10710107

retrieved

9 December 2017

cites work

Infliximab for the treatment of fistulas in patients with Crohn's disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2000.01872.X

retrieved

21 January 2018

Chimeric anti-TNF-alpha monoclonal antibody cA2 binds recombinant transmembrane TNF-alpha and activates immune effector functions

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2000.01872.X

retrieved

21 January 2018

A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2000.01872.X

retrieved

21 January 2018

Identifiers

DOI

10.1111/J.1572-0241.2000.01872.X

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10710107

retrieved

9 December 2017

PubMed publication ID

10710107

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10710107

retrieved

9 December 2017

(Q45111702)

Does administration of infliximab increase susceptibility to listeriosis?

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)